TEANECK, N.J., June 17, 2016 -- Holy Name Medical Center is the first hospital in the NY/NJ metropolitan area to use digital monitoring technology to continuously track patients' vital signs. The ViSi® Mobile device, about the size of a business card, is worn on the wrist and transmits patient information to clinicians on an ongoing basis. It is the first body-worn monitor able to non-invasively measure all core vital signs including blood pressure, heart or pulse rate, electrocardiogram or heart rhythm, blood oxygenation, respiration rate and skin temperature. The system will enhance patient safety by enabling early detection of patient deterioration and help ensure a successful response to rescue situations.
"We are always looking for ways to improve the patient experience," said Sheryl Slonim, DNP, RN-BC, NEA-BC, APN-C, Executive Vice President, Patient Care Services and Chief Nursing Officer. "The monitoring system runs on the hospital's wireless network, and any abnormal changes in patients' vital signs are sent to their primary nurses so they can receive immediate attention which will help prevent adverse outcomes."
Typically, nurses check patient vital signs during routine rounds that occur every 6-8 hours. The intermittent checks can disturb patients, while only providing snapshots of vital sign data rather than continuous information. With the ViSi system, if a patient's vital signs move beyond selected ranges the system's alarm system will warn clinicians, so the appropriate intervention can be taken.
In addition to supporting safety, the system also aligns with Holy Name's ongoing efforts to improve the overall healing experience. The lightweight device promotes mobility – patients are able to get out of bed, walk around, shower and undergo physical therapy – all while remaining connected to clinicians.
"The number one benefit is improved patient safety," says Michael Maron, President and CEO. "While real-time patient monitoring is a trend that is just beginning to take hold in leading medical institutions throughout the nation, Holy Name has been testing this technology for years in conjunction with the Telemedicine and Advanced Technology Research Center of the US Department of Defense. Integrating the ViSi Mobile Technology System into our patient care model supports the hospital's long-standing commitment to delivering the highest standard of patient care and patient safety."
ABOUT HOLY NAME MEDICAL CENTER
Holy Name Medical Center is a fully accredited, not-for-profit healthcare facility based in Teaneck, New Jersey. Founded and sponsored by the Sisters of St. Joseph of Peace in 1925, the comprehensive 361-bed medical center offers leading-edge medical practice and technology administered in an environment rooted in a tradition of compassion and respect for every patient. Holy Name provides high quality health care across a continuum that encompasses education, prevention, early intervention, comprehensive treatment options, rehabilitation and wellness maintenance. To learn more, visit HolyName.org.
CONTACT: Katherine Emmanouilidis
Director, Public Relations & Marketing
Holy Name Medical Center
718 Teaneck Road | Teaneck, NJ 07666
Tel: 201-227-6047
[email protected]


OpenAI Addresses Security Vulnerability in macOS App Certification Process
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 



